Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Fibrosis.php on line 2
Fibrosis
LE WE PMID CA
Fibrosis903Fibrose

Adenosine

Alcohol

Apoptotic bodies

Autoantibodies Anti PDGF receptor stimulatory

Caveolin and caveoles

Chymase

Collagen

Deoxycorticosterone

Endocannabinoid

Endothelio mesenchymal transition

Epithelio mesenchymal transition

ERS UFR (Toxikologie)

Fibroblast

Fibrocyte

Fibrosis

Follistatin

Graves disease

HGF

Histone deacetylase

IGFBP5

Imatinib

Interleukin6

Intravenous immunoglobulin

Keloid

Kidney (Chronic renal failure)

Kidney (Fibrosis)

Kidney (Progression of renal disease)

Lysophosphatidate

Lysyl oxidase

Macrophages

Mechanotransduction

Melatonin

Mitomycin c

Myofibroblast

N Acetylcysteine

NADPH oxidase

Neoplasia (Tumor biology and immunology)

PTH (Hyperparathyreoidism secondary)

PTHRP

RAAS (Renin angiotensin system)

Rac

Receptor (Adenosine)

Receptor (PPAR)

Receptor (Pro Renin)

Redox (BASKET)

Regeneration of tissues and other biologic structures

Relaxin

Remodeling

Sclerodermia

Skin (Pathology)

SMAD2

SMAD3

SNAIL

SnoN

Superoxide dismutase SOD

Syndecan

T cell (Th2)

TGF beta

TGIF

Thrombospondin

TNF alpha converting enzyme

Trachea (Stenosis)

TRPV1

Vitamin D3 (Calcitriol)

Wnt beta Catenin TCF

2003  
1
Fibrosis regression induced by intravenous gammaglobulin treatment.
[12525390] Ann Rheum Dis 62(2): 175-7 (2003)
2008  
2
2002  
3
Transforming growth factor-beta signal transduction and progressive renal disease.
[12486204] Exp Biol Med (Maywood) 227(11): 943-56 (2002)
2008  
4
Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis.
[18668575] Arthritis Rheum 58(8): 2219-24 (2008)
2008  
5
Hypoxia-inducible factor signaling in the development of tissue fibrosis.
[18418042] Cell Cycle 7(9): 1128-32 (2008)
2002  
6
Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy.
[12480810] Circ Res 91(12): 1103-13 (2002)
2006  
7
Peroxisome proliferator-activated receptor gamma agonists in renal disease.
[16645006] Eur J Endocrinol 154(5): 613-21 (2006)
2007  
8
Fibrosis and diseases of the eye.
[17332885] J Clin Invest 117(3): 576-86 (2007)
2007  
9
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.
[17332881] J Clin Invest 117(3): 539-48 (2007)
2007  
10
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.
[17332879] J Clin Invest 117(3): 524-9 (2007)
2005  
11
2004  
12
Pulmonary fibrosis: thinking outside of the lung.
[15286797] J Clin Invest 114(3): 319-21 (2004)
2009  
13
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review).
[19578787] Int J Mol Med 24(2): 143-52 (2009)
2008  
14
The controversial role of tumor necrosis factor alpha in fibrotic diseases.
[18668576] Arthritis Rheum 58(8): 2228-35 (2008)
2009  
15
Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology.
[19333918] Arthritis Rheum 60(4): 907-11 (2009)
2003  
16
Wnt signaling and pulmonary fibrosis.
[12707021] Am J Pathol 162(5): 1393-7 (2003)
2009  
17
Emerging concepts in the pathogenesis of lung fibrosis.
[19497999] Am J Pathol 175(1): 3-16 (2009)
2005  
18
A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.
[16049317] Am J Pathol 167(2): 301-4 (2005)
2009  
19
Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.
[19729474] Am J Pathol 175(4): 1362-70 (2009)
2008  
20
Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.
[18006606] Am J Physiol Gastrointest Liver Physiol 294(2): G357-62 (2008)
2010  
21
Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects.
[20472764] Am J Physiol Heart Circ Physiol 299(1): H1-9 (2010)
2009  
22
Could N-acetylcysteine slow progression of idiopathic pulmonary fibrosis by inhibiting EMT?
[19700642] Am J Physiol Lung Cell Mol Physiol 297(5): L803-4 (2009)
2008  
23
2008  
24
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.
[18203815] Am J Physiol Lung Cell Mol Physiol 294(5): L843-61 (2008)
2008  
25
Lysophosphatidic acid and renal fibrosis.
[18455518] Biochim Biophys Acta 1781(9): 582-7 (2008)
2010  
26
Signaling pathways in the epithelial origins of pulmonary fibrosis.
[20676040] Cell Cycle 9(14): 2769-76 (2010)
2007  
27
Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis?
[17374993] Cell Cycle 6(6): 638-42 (2007)
2011  
28
Targeting collagen expression in alcoholic liver disease.
[21633652] World J Gastroenterol 17(20): 2473-81 (2011)
2007  
29
Transforming growth factor-beta and fibrosis.
[17589920] World J Gastroenterol 13(22): 3056-62 (2007)
2007  
30
Role of iron in hepatic fibrosis: one piece in the puzzle.
[17729396] World J Gastroenterol 13(35): 4746-54 (2007)
2009  
31
Renin-angiotensin system in the pathogenesis of liver fibrosis.
[19496186] World J Gastroenterol 15(21): 2579-86 (2009)
2010  
32
Syndecan-1: a critical mediator in cardiac fibrosis.
[20048190] Hypertension 55(2): 233-5 (2010)
2006  
33
Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?
[16880183] Nephrol Dial Transplant 21(10): 2696-702 (2006)
2006  
34
Renal fibrosis and the origin of the renal fibroblast.
[16887850] Nephrol Dial Transplant 21(12): 3368-70 (2006)
2003  
35
The thrombospondin 1-TGF-beta axis in fibrotic renal disease.
[12808154] Nephrol Dial Transplant 18(7): 1241-5 (2003)
2007  
36
Molecular targets in pulmonary fibrosis: the myofibroblast in focus.
[17934117] Chest 132(4): 1311-21 (2007)
2010  
37
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation.
[20538689] Circ Res 106(11): 1675-80 (2010)
2010  
38
Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
[20133912] Circ Res 106(2): 272-84 (2010)
2009  
39
"Obese" smooth muscle cells fail to assemble collagen fibrils.
[19359604] Circ Res 104(7): 826-8 (2009)
2011  
40
A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury.
[21052497] J Biomed Biotechnol 2011(-): 290874 (2011)
2007  
41
TGFbeta, cardiac fibroblasts, and the fibrotic response.
[16919613] Cardiovasc Res 74(2): 207-12 (2007)
2007  
42
TGF-beta signaling in vascular fibrosis.
[17376414] Cardiovasc Res 74(2): 196-206 (2007)
2008  
43
Fibrogenesis of parenchymal organs.
[18403330] Proc Am Thorac Soc 5(3): 338-42 (2008)
2008  
44
What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis.
[18403324] Proc Am Thorac Soc 5(3): 305-10 (2008)
2006  
45
Epithelial origin of myofibroblasts during fibrosis in the lung.
[16738204] Proc Am Thorac Soc 3(4): 377-82 (2006)
2006  
46
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.
[16799085] Proc Am Thorac Soc 3(5): 418-23 (2006)
2006  
47
Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.
[16799084] Proc Am Thorac Soc 3(5): 413-7 (2006)
2007  
48
Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
[17396129] Cell Death Differ 14(7): 1343-9 (2007)
2007  
49
Therapeutic potential of follistatin to promote tissue regeneration and prevent tissue fibrosis.
[17938504] Endocr J 54(6): 849-54 (2007)
2010  
50
New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage.
[20675958] J Pharmacol Sci 113(4): 301-9 (2010)
2009  
51
Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.
[19151536] J Pharmacol Sci 109(1): 20-3 (2009)
2010  
52
Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.
[19850147] Int J Biochem Cell Biol 42(4): 535-42 (2010)
2009  
53
Imatinib as a novel therapeutic approach for fibrotic disorders.
[19029132] Rheumatology (Oxford) 48(1): 2-4 (2009)
2008  
54
Role of PDGF in fibrotic diseases and systemic sclerosis.
[18784131] Rheumatology (Oxford) 47 Suppl 5(-): v2-4 (2008)
2008  
55
Criteria to select molecular targets for anti-fibrotic therapy.
[18784127] Rheumatology (Oxford) 47 Suppl 5(-): v12-3 (2008)
2008  
56
Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis.
[18784126] Rheumatology (Oxford) 47 Suppl 5(-): v10-1 (2008)
2008  
57
Extracellular superoxide dismutase in pulmonary fibrosis.
[17999630] Antioxid Redox Signal 10(2): 343-54 (2008)
2008  
58
Antioxidants as potential therapeutics for lung fibrosis.
[17999627] Antioxid Redox Signal 10(2): 355-70 (2008)
2008  
59
The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.
[17961066] Antioxid Redox Signal 10(2): 287-301 (2008)
2011  
60
Resolving the scar of pulmonary fibrosis.
[21992127] N Engl J Med 365(12): 1140-1 (2011)
2004  
61
Regression of liver fibrosis in patients treated by interferon.
[15575231] Intern Med 43(10): 887-8 (2004)
2009  
62
Rationale and targets for antifibrotic therapies.
[19726145] Gastroenterol Clin Biol 33(10-11): 949-57 (2009)
2005  
63
IL-6 and extracellular matrix remodeling.
[16266225] Rev Esp Enferm Dig 97(8): 575-95 (2005)
2004  
64
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.
[15180923] Am J Physiol Renal Physiol 287(1): F7-16 (2004)
2003  
65
TGF-beta signal transduction and mesangial cell fibrogenesis.
[12529270] Am J Physiol Renal Physiol 284(2): F243-52 (2003)
2004  
66
Fibrotic disease and the T(H)1/T(H)2 paradigm.
[15286725] Nat Rev Immunol 4(8): 583-94 (2004)
2008  
67
Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5.
[18676497] J Endocrinol 199(2): 155-64 (2008)
2007  
68
2009  
69
Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats.
[19322917] World J Gastroenterol 15(12): 1452-8 (2009)
2010  
70
Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes.
[20522592] Diabetes 59(8): 2033-42 (2010)
2010  
71
MicroRNAs and the regulation of fibrosis.
[20412055] FEBS J 277(9): 2015-21 (2010)
2010  
72
Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.
[19800967] Free Radic Biol Med 48(1): 1-15 (2010)
2011  
73
Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-beta/Smad signaling in DOCA-salt hypertension.
[21792478] Mol Med 17(11-12): 1204-12 (2011)
2010  
74
Molecular pathogenesis of skin fibrosis: insight from animal models.
[20425530] Curr Rheumatol Rep 12(1): 26-33 (2010)
2009  
75
Innovative approaches to the therapy of fibrosis.
[19667993] Curr Opin Rheumatol 21(6): 649-55 (2009)
2008  
76
2008  
77
Oxidative and nitrosative stress and fibrogenic response.
[18984466] Clin Liver Dis 12(4): 769-90, viii (2008)
2008  
78
Cellular and molecular mechanisms of fibrosis.
[18161745] J Pathol 214(2): 199-210 (2008)
2010  
79
2010  
80
Macrophages: master regulators of inflammation and fibrosis.
[20665377] Semin Liver Dis 30(3): 245-57 (2010)
2011  
81
Scraping fibrosis: expressway to the core of fibrosis.
[21546973] Nat Med 17(5): 552-3 (2011)
2007  
82
Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?
[17211838] J Cell Biochem 101(4): 830-9 (2007)
2010  
83
Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment.
[20968196] J Med Life 3(2): 122-7 (2010)
2010  
84
The origin of fibroblasts and mechanism of cardiac fibrosis.
[20635395] J Cell Physiol 225(3): 631-7 (2010)
2008  
85
Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review.
[18632420] Eur Cytokine Netw 19(2): 69-80 (2008)
2009  
86
Relaxin and its role in the development and treatment of fibrosis.
[19524867] Transl Res 154(1): 1-6 (2009)
2011  
87
Adenosine receptors and fibrosis: a translational review.
[22003368] F1000 Biol Rep 3(-): 21 (2011)
2010  
88
Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives.
[21170369] F1000 Biol Rep 2(-): 78 (2010)
2010  
89
Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality.
[20359533] J Steroid Biochem Mol Biol 121(1-2): 193-8 (2010)
2008  
90
Immune mechanisms in thyroid eye disease.
[18752427] Thyroid 18(9): 959-65 (2008)
2011  
91
The role of fibrocytes in fibrotic diseases of the lungs and heart.
[21219601] Fibrogenesis Tissue Repair 4(-): 2 (2011)
2009  
92
2009  
93
Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art.
[20003476] Fibrogenesis Tissue Repair 2(-): 7 (2009)
2008  
94
Redox mechanisms in hepatic chronic wound healing and fibrogenesis.
[19014652] Fibrogenesis Tissue Repair 1(1): 5 (2008)
2007  
95
Mechanoregulation of gene expression in fibroblasts.
[17331678] Gene 391(1-2): 1-15 (2007)
2011  
96
Navigating the challenges of fibrosis assessment: land in sight?
[21127139] J Am Soc Nephrol 22(1): 11-3 (2011)
2011  
97
Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis.
[20663704] Farm Hosp 35(1): 32-5 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Fibrosis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Fibrosis.php on line 92